Zdrowie i gospodarka · 28/02/2013

FDA Releases Draft Guidance on Pediatric Information in Prescription Drug Labeling

The FDA has made available a draft guidance document to help industry and review staff determine the placement and content of pediatric information in human prescription drug and biological product labeling, in compliance with the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.